News and Announcements
Ledgerium has become the first strategical incubation project of LEEK eco-fund
- Published August 28, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
According to LEEK News updates, Ledgerium has recently been appointed as the first strategical incubation project of the LEEK eco-fund. Ledgerium aims to improve traditional audit procedure, build a new credit mechanism and reshape the accounting industry by creating a decentralized Blockchain ledger through a triple entry accounting system. Prior to this, Ledgerium has been already funded from Collinstar Capital, Horman Capital, HAYEK capital and Blockchain Australia.
Jayden Wei, the founder of LEEK, said the existing form of “Company” or “Organization” will be disrupted when Ledgerium record all financial and daily operating data or documents for companies and other entities on Blockchain, which will allow legal issues to be tackled by code and the issues of human resource functions to be resolved by Token Economy.
About Ledgerium
Ledgerium seeks to renovate the traditional accounting industry and make auditing procedure to be more efficient, cost-effective and transparent. We revolutionarily bring Blockchain technology into Audit and Accounting industry to promote changes. The LGUM tokens are on sale now and the decentralised accounting ledger system that provides Blockchain as a Service (BaaS) is coming soon.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
